However, in the presence of coronary artery disease and localized or generalized atheromatosis, a question arises regarding the impact of hemoconcentration’s secondary effect related to the use of SGLT2 inhibitors in producing osmotic diuresis. Here, SLC5A2 is linked to coronary artery disorder.